Positive Results Reported For ALS Treatment By Major Medical Company

NeuroSense Makes Significant Strides in ALS Treatment with Positive Phase 2b Trial Results.

Disclaimer: This post includes links to sources of information. No ownership, affiliate interests, payment, or material support has been received from the mentioned institutions or persons.

In a pivotal development for the treatment of Amyotrophic Lateral Sclerosis (ALS), NeuroSense Therapeutics Ltd. (Nasdaq: NRSN) has reported additional positive result…